Is GSFD or JNJ a better dividend investment in 2026?

GSFD currently yields 2760.91% with a 5% 5-year dividend growth rate. JNJ yields 3.36% with 5.8% growth. The better choice depends on your goal: GSFD offers higher current income.

What is the dividend yield difference between GSFD and JNJ?

GSFD has a forward dividend yield of 2760.91% ($2.00/share annually). JNJ yields 3.36% ($4.96/share annually). The yield gap is 2757.55 percentage points.

Home › Compare › GSFD vs JNJ

GSFD vs JNJ: Dividend Comparison 2026

GSFD yields 2760.91% · JNJ yields 3.36%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GSFD wins by $206334347642.42M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GSFD

● Live price

2760.91%

Share price

$0.07

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$206334347642.44M

Annual income

$192,610,786,326,095,000.00

Full GSFD calculator →

JNJ

Johnson & Johnson

● Live price

3.36%

Share price

$147.50

Annual div

$4.96

5Y div CAGR

5.8%

Payout ratio

55%

After 10 yrs · $10,000 · DRIP

Portfolio value

$20.0K

Annual income

$827.78

Full JNJ calculator →

Portfolio growth — GSFD vs JNJ

📍 GSFD pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GSFD	JNJ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GSFD + JNJ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GSFD pays

JNJ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GSFD

Annual income on $10K today (after 15% tax)

$234,676.97/yr

After 10yr DRIP, annual income (after tax)

$163,719,168,377,180,770.00/yr

JNJ

Annual income on $10K today (after 15% tax)

$285.83/yr

After 10yr DRIP, annual income (after tax)

$703.61/yr

At 15% tax rate, GSFD beats the other by $163,719,168,377,180,060.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GSFD + JNJ for your $10,000?

GSFD: 50%JNJ: 50%

100% JNJ50/50100% GSFD

Portfolio after 10yr

$103167173821.23M

Annual income

$96,305,393,163,047,920.00/yr

Blended yield

93.35%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

GSFD

No analyst data

Altman Z

0.5

Piotroski

1/9

JNJ

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$228.73

+55.1% upside vs current

Range: $190.00 — $265.00

Altman Z

5.2

Piotroski

4/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GSFD buys

JNJ buys

No recent congressional trades found for GSFD or JNJ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGSFDJNJ

Forward yield	2760.91% ✓	3.36%
Annual dividend / share	$2.00	$4.96 ✓
Payout ratio	50% ✓	55%
1-year div growth	0%	4.2% ✓
5-year div CAGR	0%	5.8% ✓
Portfolio after 10y	$206334347642.44M ✓	$20.0K
Annual income after 10y	$192,610,786,326,095,000.00 ✓	$827.78
Total dividends collected	$205381137054.50M ✓	$5.6K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: GSFD vs JNJ ($10,000, DRIP)

Year	GSFD Portfolio	GSFD Income/yr	JNJ Portfolio	JNJ Income/yr	Gap
1← crossover	$286,791	$276,090.56	$10,676	$355.77	+$276.1K → GSFD
2	$7,706,881	$7,400,015.42	$11,407	$389.39	+$7.70M → GSFD
3	$194,096,408	$185,850,044.68	$12,198	$426.53	+$194.08M → GSFD
4	$4,582,075,357	$4,374,392,200.78	$13,056	$467.62	+$4582.06M → GSFD
5	$101,414,232,866	$96,511,412,233.78	$13,987	$513.12	+$101414.22M → GSFD
6	$2,104,839,745,904	$1,996,326,516,737.79	$14,998	$563.56	+$2104839.73M → GSFD
7	$40,975,082,919,702	$38,722,904,391,584.13	$16,098	$619.52	+$40975082.90M → GSFD
8	$748,349,752,637,496	$704,506,413,913,414.90	$17,295	$681.69	+$748349752.62M → GSFD
9	$12,825,758,239,574,374	$12,025,024,004,252,254.00	$18,599	$750.82	+$12825758239.56M → GSFD
10	$206,334,347,642,439,580	$192,610,786,326,095,000.00	$20,022	$827.78	+$206334347642.42M → GSFD

GSFD vs JNJ: Complete Analysis 2026

GSFD — Stock

Global Seafood Technologies, Inc. engages in the processing and packaging of shrimp for seafood restaurant chains and retail grocery outlets in the United States. The company operates through the Seafood, Fishing Bait, and Freshwater Shrimp segments. The Seafood segment performs processing, packaging, and storage of shrimp and other seafood products. The company provides frozen shrimp in various sizes and descriptions, which are packaged for commercial or consumer use. Frozen, headless shrimp with shell, is the principal product processed and packaged in one-pound and two-pound packages. Peeled shrimp is also processed under private labels for customers or for distribution to restaurants, and it is used in ready-to-cook meal kits for supermarket distribution. The Fishing Bait segment packages and distributes recreational fishing bait products. Its Killer Bee Bait products include varieties of bait shrimp, catfish bait, cut squid, whole squid, cigar minnows, ballyhoo, frozen chum, and menhaden oil. Killer Bee Bait products are sold through retail outlets and at independent marinas and bait shops. The Freshwater Shrimp segment engages in the development and harvesting of farm-grown and freshwater shrimp through its hatchery and nursery facility for sale to independent aquaculture farmers. Global Seafood Technologies is based in Biloxi, Mississippi.

Full GSFD Calculator →

JNJ — Healthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →

📬

Get this GSFD vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GSFD vs SCHD GSFD vs JEPI GSFD vs O GSFD vs KO GSFD vs MAIN GSFD vs ABBV GSFD vs MRK GSFD vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.